Novo Nordisk (NVO) has released an update.
Novo Nordisk A/S, a global healthcare leader, announced the sale of 6,311,250 shares by board members, executives, and associated persons, at a price of DKK 860.02 per share, totaling DKK 5,427,801,225. The transaction, detailed in the company’s latest report, took place outside of trading venues on May 6, 2024. This move reflects the ongoing financial activities of Novo Nordisk’s insiders and could be of interest to investors monitoring the company’s stock.
For further insights into NVO stock, check out TipRanks’ Stock Analysis page.
